We are paid only by covered entities. That's the whole model.
Unlike wholesaler-owned or PBM-owned platforms, we sell no software, take no vendor revenue, and are paid only by the covered entities we work for.
An explicit statement, not a marketing line.
This independence is a structural fact about how we're compensated, and it directly shapes what we're able to tell a client.
- 01No revenue from wholesalers, GPOs, or distributors
- 02No revenue from pharmacy benefit managers (PBMs)
- 03No revenue from drug manufacturers
- 04No revenue or referral fees from third-party administrators (TPAs) or split-billing software vendors
- 05We are compensated only by the covered entities that engage us
An assessment with nothing riding on the answer.
Independence only matters if it changes what we're willing to tell you. Structurally, it costs us nothing to say your current setup is already working.
Why this matters
Most of the vendors a covered entity interacts with in the course of running a 340B program are compensated, at least in part, by parties other than the entity itself — a software fee tied to transaction volume, a placement arrangement, a bundled service relationship. None of that makes those vendors dishonest. It does mean an entity rarely gets an assessment from someone with no stake in the answer.
Because we sell nothing else, telling a client their current setup is already working costs us nothing — and telling them it isn't costs us nothing either. That's the entire point of hiring an independent review.
Next step
See what an independent review actually looks like.
Start with a TPA performance review or a mock audit — either way, no software pitch at the end of it.